IGM Biosciences, Inc. Annual Return On Equity in % from 2018 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
IGM Biosciences, Inc. quarterly/annual Return On Equity history and growth rate from 2018 to 2023.
  • IGM Biosciences, Inc. Return On Equity for the quarter ending September 30, 2024 was -155 %, a 69.4% decline year-over-year.
  • IGM Biosciences, Inc. annual Return On Equity for 2023 was -103 %, a 39.5% decline from 2022.
  • IGM Biosciences, Inc. annual Return On Equity for 2022 was -74 %, a 35.3% decline from 2021.
  • IGM Biosciences, Inc. annual Return On Equity for 2021 was -54.7 %, a 68.1% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -103 -29.2 -39.5% Jan 1, 2023 Dec 31, 2023
2022 -74 -19.3 -35.3% Jan 1, 2022 Dec 31, 2022
2021 -54.7 -22.2 -68.1% Jan 1, 2021 Dec 31, 2021
2020 -32.5 +18.1 +35.8% Jan 1, 2020 Dec 31, 2020
2019 -50.6 -97.2 -209% Jan 1, 2019 Dec 31, 2019
2018 46.6 Jan 1, 2018 Dec 31, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.